LeMaitre Vascular, Inc. (LMAT)
USD 90.34
(-0.65%)
USD 90.34
(-0.65%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 52.33 Million USD | 4.1% |
| 2022 | 50.27 Million USD | 9.04% |
| 2021 | 46.1 Million USD | 2.19% |
| 2020 | 45.11 Million USD | 14.14% |
| 2019 | 39.52 Million USD | 44.32% |
| 2018 | 27.38 Million USD | 30.13% |
| 2017 | 21.04 Million USD | 7.5% |
| 2016 | 19.57 Million USD | 28.76% |
| 2015 | 15.2 Million USD | -9.03% |
| 2014 | 16.71 Million USD | 26.1% |
| 2013 | 13.25 Million USD | 22.06% |
| 2012 | 10.85 Million USD | 35.69% |
| 2011 | 8 Million USD | -4.44% |
| 2010 | 8.37 Million USD | 28.89% |
| 2009 | 6.49 Million USD | -6.62% |
| 2008 | 6.95 Million USD | -27.43% |
| 2007 | 9.58 Million USD | 57.69% |
| 2006 | 6.08 Million USD | 18.15% |
| 2005 | 5.14 Million USD | 57.3% |
| 2004 | 3.27 Million USD | 0.0% |
| 2002 | - USD | 0.0% |
| 2001 | - USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 54.49 Million USD | 4.13% |
| 2024 Q2 | 56.65 Million USD | 3.97% |
| 2024 Q3 | 65.02 Million USD | 14.76% |
| 2023 Q4 | 52.33 Million USD | -6.86% |
| 2023 FY | 52.33 Million USD | 4.1% |
| 2023 Q1 | 53.77 Million USD | 6.98% |
| 2023 Q2 | 53.83 Million USD | 0.1% |
| 2023 Q3 | 56.18 Million USD | 4.38% |
| 2022 Q2 | 47.19 Million USD | 1.13% |
| 2022 Q3 | 47.71 Million USD | 1.1% |
| 2022 Q4 | 50.27 Million USD | 5.37% |
| 2022 Q1 | 46.66 Million USD | 1.21% |
| 2022 FY | 50.27 Million USD | 9.04% |
| 2021 Q4 | 46.1 Million USD | 4.01% |
| 2021 FY | 46.1 Million USD | 2.19% |
| 2021 Q1 | 45.07 Million USD | -0.1% |
| 2021 Q2 | 44.75 Million USD | -0.71% |
| 2021 Q3 | 44.32 Million USD | -0.95% |
| 2020 Q3 | 45.63 Million USD | -1.51% |
| 2020 Q4 | 45.11 Million USD | -1.15% |
| 2020 Q2 | 46.34 Million USD | 14.19% |
| 2020 Q1 | 40.58 Million USD | 2.67% |
| 2020 FY | 45.11 Million USD | 14.14% |
| 2019 FY | 39.52 Million USD | 44.32% |
| 2019 Q3 | 36.69 Million USD | 13.81% |
| 2019 Q4 | 39.52 Million USD | 7.71% |
| 2019 Q1 | 29.4 Million USD | 7.38% |
| 2019 Q2 | 32.24 Million USD | 9.64% |
| 2018 Q1 | 21.83 Million USD | 3.74% |
| 2018 Q3 | 23.87 Million USD | 10.19% |
| 2018 Q4 | 27.38 Million USD | 14.71% |
| 2018 FY | 27.38 Million USD | 30.13% |
| 2018 Q2 | 21.66 Million USD | -0.75% |
| 2017 Q3 | 21.09 Million USD | 3.09% |
| 2017 Q1 | 20.59 Million USD | 5.2% |
| 2017 FY | 21.04 Million USD | 7.5% |
| 2017 Q4 | 21.04 Million USD | -0.23% |
| 2017 Q2 | 20.46 Million USD | -0.65% |
| 2016 Q4 | 19.57 Million USD | 12.32% |
| 2016 FY | 19.57 Million USD | 28.76% |
| 2016 Q3 | 17.43 Million USD | 2.77% |
| 2016 Q2 | 16.96 Million USD | -5.23% |
| 2016 Q1 | 17.89 Million USD | 17.7% |
| 2015 Q2 | 15.78 Million USD | -4.1% |
| 2015 Q1 | 16.45 Million USD | -1.54% |
| 2015 Q4 | 15.2 Million USD | -4.49% |
| 2015 FY | 15.2 Million USD | -9.03% |
| 2015 Q3 | 15.92 Million USD | 0.88% |
| 2014 Q1 | 14.18 Million USD | 7.02% |
| 2014 FY | 16.71 Million USD | 26.1% |
| 2014 Q2 | 14.99 Million USD | 5.7% |
| 2014 Q3 | 16.92 Million USD | 12.87% |
| 2014 Q4 | 16.71 Million USD | -1.25% |
| 2013 Q4 | 13.25 Million USD | 1.32% |
| 2013 Q1 | 11.26 Million USD | 3.74% |
| 2013 Q2 | 11.65 Million USD | 3.45% |
| 2013 Q3 | 13.08 Million USD | 12.25% |
| 2013 FY | 13.25 Million USD | 22.06% |
| 2012 FY | 10.85 Million USD | 35.69% |
| 2012 Q4 | 10.85 Million USD | 7.2% |
| 2012 Q2 | 9.12 Million USD | 10.0% |
| 2012 Q3 | 10.13 Million USD | 10.99% |
| 2012 Q1 | 8.29 Million USD | 3.67% |
| 2011 Q4 | 8 Million USD | 10.39% |
| 2011 Q1 | 9.11 Million USD | 8.87% |
| 2011 Q2 | 7.81 Million USD | -14.33% |
| 2011 Q3 | 7.25 Million USD | -7.18% |
| 2011 FY | 8 Million USD | -4.44% |
| 2010 FY | 8.37 Million USD | 28.89% |
| 2010 Q3 | 6.91 Million USD | 12.54% |
| 2010 Q2 | 6.14 Million USD | -1.79% |
| 2010 Q1 | 6.25 Million USD | -3.79% |
| 2010 Q4 | 8.37 Million USD | 21.2% |
| 2009 Q4 | 6.49 Million USD | 0.05% |
| 2009 FY | 6.49 Million USD | -6.62% |
| 2009 Q2 | 7 Million USD | -2.3% |
| 2009 Q1 | 7.16 Million USD | 2.96% |
| 2009 Q3 | 6.49 Million USD | -7.21% |
| 2008 Q1 | 10.26 Million USD | 7.06% |
| 2008 FY | 6.95 Million USD | -27.43% |
| 2008 Q4 | 6.95 Million USD | -14.12% |
| 2008 Q3 | 8.1 Million USD | -16.1% |
| 2008 Q2 | 9.65 Million USD | -5.92% |
| 2007 FY | 9.58 Million USD | 57.69% |
| 2007 Q1 | 7.1 Million USD | 16.91% |
| 2007 Q2 | 7.33 Million USD | 3.18% |
| 2007 Q3 | 8.14 Million USD | 11.06% |
| 2007 Q4 | 9.58 Million USD | 17.71% |
| 2006 FY | 6.08 Million USD | 18.15% |
| 2006 Q4 | 6.08 Million USD | 1.16% |
| 2006 Q3 | 6.01 Million USD | 5.92% |
| 2006 Q1 | 5.39 Million USD | 4.76% |
| 2006 Q2 | 5.67 Million USD | 5.25% |
| 2005 FY | 5.14 Million USD | 57.3% |
| 2005 Q4 | 5.14 Million USD | 0.0% |
| 2004 Q4 | 3.27 Million USD | 0.0% |
| 2004 FY | 3.27 Million USD | 0.0% |
| 2002 FY | - USD | 0.0% |
| 2001 FY | - USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 17.87 Million USD | -192.739% |
| AngioDynamics, Inc. | 60.61 Million USD | 13.665% |
| AtriCure, Inc. | 67.89 Million USD | 22.923% |
| Avinger, Inc. | 5.29 Million USD | -887.788% |
| Azenta, Inc. | 128.19 Million USD | 59.178% |
| BioLife Solutions, Inc. | 43.45 Million USD | -20.428% |
| The Cooper Companies, Inc. | 735.6 Million USD | 92.886% |
| Daxor Corporation | - USD | -Infinity% |
| Ekso Bionics Holdings, Inc. | 5.05 Million USD | -936.297% |
| Femasys Inc. | 667.11 Thousand USD | -7744.639% |
| GlucoTrack, Inc. | - USD | -Infinity% |
| Harvard Bioscience, Inc. | 24.71 Million USD | -111.737% |
| Hologic, Inc. | 679.8 Million USD | 92.302% |
| ICU Medical, Inc. | 709.36 Million USD | 92.623% |
| Intuitive Surgical, Inc. | 1.22 Billion USD | 95.713% |
| KORU Medical Systems, Inc. | 3.48 Million USD | -1403.26% |
| Innovative Eyewear, Inc. | 856.75 Thousand USD | -6008.252% |
| Innovative Eyewear, Inc. | 856.75 Thousand USD | -6008.252% |
| Masimo Corporation | 545 Million USD | 90.398% |
| Microbot Medical Inc. | - USD | -Infinity% |
| Meihua International Medical Technologies Co., Ltd. | 1.61 Million USD | -3135.975% |
| Merit Medical Systems, Inc. | 303.87 Million USD | 82.778% |
| Nephros, Inc. | 2.47 Million USD | -2018.745% |
| NovoCure Limited | 38.15 Million USD | -37.17% |
| NEXGEL, Inc. | 1.31 Million USD | -3867.627% |
| NEXGEL, Inc. | 1.31 Million USD | -3867.627% |
| Singular Genomics Systems, Inc. | 13.57 Million USD | -285.595% |
| OraSure Technologies, Inc. | 47.61 Million USD | -9.911% |
| Pro-Dex, Inc. | 15.26 Million USD | -242.74% |
| Pulse Biosciences, Inc. | - USD | -Infinity% |
| Predictive Oncology Inc. | 494.37 Thousand USD | -10485.71% |
| Precision Optics Corporation, Inc. | 2.86 Million USD | -1724.657% |
| QuidelOrtho Corporation | 577.8 Million USD | 90.943% |
| Repligen Corporation | 202.32 Million USD | 74.134% |
| Sanara MedTech Inc. | 4.71 Million USD | -1009.33% |
| STAAR Surgical Company | 35.13 Million USD | -48.97% |
| Sharps Technology, Inc. | 1.7 Million USD | -2961.958% |
| Utah Medical Products, Inc. | 9.58 Million USD | -446.159% |
| DENTSPLY SIRONA Inc. | 624 Million USD | 91.613% |
| Jin Medical International Ltd. | 5.05 Million USD | -935.654% |